Scudiero, Fernando
Canonico, Mario E.
Sanna, Giuseppe D.
Dossi, Filippo
Silverio, Angelo
Galasso, Gennaro
Esposito, Giovanni
Porto, Italo
Parodi, Guido http://orcid.org/0000-0001-5136-4881
Article History
Accepted: 1 February 2022
First Online: 17 February 2022
Declarations
:
: Prof. Guido Parodi reported receiving consulting or lecture fees from AstraZeneca, Bayer, Chiesi, Daiichi Sankyo/Eli Lilly, and Merck Sharp Dohme. All other authors declare no competing interests.